Skip to content

Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males

Effect of Oral Caffeine and L-Citrulline Supplementation on Arterial Function in Healthy Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02214290
Enrollment
16
Registered
2014-08-12
Start date
2012-09-30
Completion date
2014-03-31
Last updated
2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Hypertension

Keywords

Cardiovascular, Caffeine, L-citrulline, Arterial Function, Hemodynamics, Blood Pressure, Pulse Wave Velocity, Pulse Wave Analysis

Brief summary

Caffeine is an exceedingly popular and consumed pharmacological agent. Although caffeine is primarily consumed from coffee and tea beverages, it is also available in other forms such as sodas, energy drinks, tablets and capsules. Nevertheless, caffeine acutely increases brachial and aortic systolic blood pressure (BP) and arterial stiffness. Arterial stiffness is an independent predictor of cardiovascular disease (CVD) and assessed through pulse wave velocity (PWV). Interestingly, previous studies have proposed that caffeine may increase aortic BP through increases in aortic PWV and augmentation index (AIx), a measurement of wave reflection. Yet, these effects were seen in middle-aged adults with treated hypertension and a wide age range. Therefore, it is imperative to consider that caffeine may cause different effects in young normotensive individuals than in older adults independently of BP levels. Importantly, oral supplementation of the amino-acid, L-citrulline has been shown to enhance the bioavailability of L-arginine levels and nitric oxide (NO) production and, therefore, improve arterial function. L-citrulline supplementation for 7 days given at 6 g/day has shown to increase NO levels while improving PWV. Previous studies by our group also demonstrated that L-citrulline supplementation reduces the BP response to cold exposure; a condition with an increased vasoconstriction. Therefore, the acute effects of caffeine on central and peripheral PWV and BP in healthy young men are yet to be fully evaluated. We hypothesized that acute caffeine intake would increase peripheral and aortic BP and PWV and that L-citrulline supplementation would attenuate the effects induced by acute caffeine ingestion.

Detailed description

The specific aims of this study are: AIM 1: To examine the effects of the acute ingestion of 200mg caffeine (tablets) on arterial function in young adults. The working hypothesis is that acute caffeine intake would increase brachial, ankle and aortic BP, PWV (aortic and leg), and wave reflection. In order to test this hypothesis, the investigators will perform non-invasive measurements of arterial stiffness (aortic and leg PWV) and pulse wave analysis (aortic BP and AIx) using applanation tonometry of the radial artery 30, 45, and 60 minutes following caffeine ingestion. AIM 2: To determine the effectiveness of L-citrulline supplementation to attenuate the acute cardiovascular effects of caffeine ingestion. The working hypothesis is that 7 days of L-citrulline supplementation will attenuate the unfavorable arterial responses (increases in BP, PWV, and wave reflection) to acute caffeine ingestion. In order to test this hypothesis, the investigators will perform the same procedures previously specified in AIM 1. Description of the study: Sixteen healthy young men 18-40 years of age will be enrolled in this study. Participants with CVD history, resting BP (\> 160/100 mmHg), recent history of smoking, or considered competitive athlete will be excluded from the study. All subjects will refrain from food and caffeine for \> 8 hours and from exercise for \> 24 hours before testing. Study design: Following an initial screening, arterial function measurements will be collected. Measurements will be assessed at baseline following 10 minutes of rest in the supine position and then again at 30, 45, and 60 minutes after 200 mg caffeine or placebo ingestion. Participants will receive caffeine or placebo supplementation on two separate visits with a minimum of 48 hours in between sessions. Following the acute phase of the study, subjects will be randomized to consume L-citrulline or placebo for 7 days given at 6 grams/day. Following the same protocol as the acute phase with 200 mg caffeine, measurements will be collected before and after the 7 day supplementation period.

Interventions

DRUGCaffeine

A 200 mg caffeine tablet was given to subject to examine the drugs effect on arterial function.

DRUGPlacebo

A 750 mg placebo capsule (maltodextrin) was given to subjects to examine the effect of the drug on arterial function.

DIETARY_SUPPLEMENTL-citrulline

L-citrulline was used to examine the effect of the supplement on arterial function.

Sponsors

Florida State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Young healthy males * Non smoker * Non endurance trained athlete * No previous history of cardiovascular disease

Exclusion criteria

* Female * Blood pressure greater than 160/100 * Smoker

Design outcomes

Primary

MeasureTime frameDescription
Aortic Blood PressureBaseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)Aortic blood pressure at rest and 30 minutes after acute ingestion of 200 mg of caffeine before and after 7 days of either 6g/day of Citrulline or 6 g/day of Placebo.

Secondary

MeasureTime frameDescription
Changes in Reflected Wave Pressure (P2)Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)Reflected wave pressure at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.
Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)Femoral-ankle pulse wave velocity at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.

Participant flow

Recruitment details

Sixteen young healthy men participated in this study. All subjects were non-smokers, recreationally active, and free of apparent cardiovascular-metabolic diseases based on medical history.

Pre-assignment details

Of the 42 individuals screened, 16 individuals completed the intervention in its entirety.

Participants by arm

ArmCount
L-Citrulline or Placebo
Placebo and L-Citrulline pills produced by NOW FOODS, USA Citrulline or Placebo (both 6g/day) were given for a 7 day supplementation period. This was followed by a 14 day washout period and crossover to the other supplement (L-Citrulline or Placebo) for 7 days. Measurements of arterial function were performed to determine if the supplements had any significant effect on blood pressure control/pressure wave reflection at rest and immediately after ingestion of 200 milligrams of caffeine.
16
Total16

Baseline characteristics

CharacteristicL-Citrulline or Placebo
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants
Age, Continuous23 years
STANDARD_DEVIATION 3
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Aortic Blood Pressure

Aortic blood pressure at rest and 30 minutes after acute ingestion of 200 mg of caffeine before and after 7 days of either 6g/day of Citrulline or 6 g/day of Placebo.

Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)

Population: Young, apparently healthy individuals, aged 18-40 years old.

ArmMeasureGroupValue (MEAN)Dispersion
CitrullineAortic Blood PressureBaseline5 mmHgStandard Deviation 1
CitrullineAortic Blood Pressure7 Days4 mmHgStandard Deviation 1
PlaceboAortic Blood PressureBaseline6 mmHgStandard Deviation 1
PlaceboAortic Blood Pressure7 Days4 mmHgStandard Deviation 1
p-value: <0.001ANOVA
Secondary

Changes in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)

Femoral-ankle pulse wave velocity at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.

Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)

Population: young, apparently healthy adults, aged 18-40 years

ArmMeasureGroupValue (MEAN)Dispersion
CitrullineChanges in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)Baseline0.6 m/sStandard Deviation 0.4
CitrullineChanges in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)7 Days0.4 m/sStandard Deviation 0.4
PlaceboChanges in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)Baseline0.7 m/sStandard Deviation 0.5
PlaceboChanges in Femoral-ankle Pulse Wave Velocity After 7 Days of Either L-Citrulline or Placebo (6g/Day)7 Days0.6 m/sStandard Deviation 0.4
p-value: <0.001ANOVA
Secondary

Changes in Reflected Wave Pressure (P2)

Reflected wave pressure at rest and 30 minutes after ingestion of 200mg of caffeine after 7 days supplementation of 6g/day of either L-Citrulline or Placebo.

Time frame: Baseline and Day 7 (Calculated change between rest and 30 minutes post-caffeine ingestion at these time points)

Population: Young, apparently healthy adults, aged 18-40 years.

ArmMeasureGroupValue (MEAN)Dispersion
CitrullineChanges in Reflected Wave Pressure (P2)Baseline5 mmHgStandard Deviation 1
CitrullineChanges in Reflected Wave Pressure (P2)7 Days4 mmHgStandard Deviation 1
PlaceboChanges in Reflected Wave Pressure (P2)Baseline5 mmHgStandard Deviation 1
PlaceboChanges in Reflected Wave Pressure (P2)7 Days5 mmHgStandard Deviation 1
p-value: <0.001ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026